ArticleRespiratory research2026
Spatial epidemiological analysis of chronic obstructive pulmonary disease in Qingdao City, China.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundExisting studies on Chronic Obstructive Pulmonary Disease (COPD) relying on voluntary questionnaire surveys have inherent limitations, while spatial epidemiological research in Qingdao remains scarce. This population census study aimed to eliminate selection bias through systematic population coverage, identify high-risk clusters using spatial analysis, and provide geospatial evidence for precision public health strategies by concurrently analyzing COPD prevalence.
methodsData were obtained from the 2023 Qingdao COPD High-Risk Population Screening Program. Using a Geographic Information System (GIS) framework, streets and towns in Qingdao City were designated as the basic spatial units for analysis. Global Moran’s I and Local Moran’s I spatial autocorrelation statistics were employed to characterize global and local spatial clustering patterns of COPD high-risk individuals and confirmed patients across the city.
resultsThe 2023 screening project identified 503,119 individuals with positive COPD Population Screener Questionnaire (COPD-PS) results (high-risk population) and 55,533 confirmed COPD patients. Gender, age, and Body Mass Index (BMI) were identified as risk factors for COPD prevalence among adults aged 40 and above in Qingdao City. Global spatial autocorrelation analysis revealed significant clustering of COPD-PS positive rates in Qingdao City (Global Moran’s I = 0.13, Z = 4.27, P < 0.001), whereas spatial autocorrelation of COPD prevalence did not reach statistical significance. Local spatial autocorrelation analysis indicated that there were significant spatial clusters of COPD high-risk populations in Shibei District and Badaxia Road Subdistrict, while no obvious clusters of COPD patients were observed.
conclusionThis large-scale census provides the first comprehensive COPD spatial epidemiology dataset for Qingdao City. GIS-derived cluster maps enable prioritization of high-burden areas for resource allocation and targeted interventions, supporting the transition to precision public health approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.